Chondrometrics GmbH

Chondrometrics GmbH is a leading provider of medical image analysis services to researchers in academia and in the pharmaceutical industry. The company focuses on quantitative analysis of articular and peri-articular tissues such as articular cartilage, meniscus, synovitis, bone, adipose tissue, and muscle. These precise measurements of tissue dimensions (morphometry) and composition (relaxometry) are obtained from magnetic resonance images (MRI) using an ISO13485 compliant medial device software and quality control (QC) process, or fully automated analysis using convolutional neural networks (CNNs). Chondrometrics' thematic focus is on the research of articular tissue development, function, and pathophysiology, particularly on osteoarthritis and the development of disease- and structure-modifying osteoarthritis drugs (DMOADs) in clinical trials with partners from the pharmaceutical industry. The key staff at Chondrometrics GmbH include CEO/CMO @Felix Eckstein, CTO @Wolfgang Wirth, and CHR @Susanne Maschek. Founded in 2003, the company has made significant strides in providing advanced medical image analysis services. However, no specific information regarding industries, headquarter location, last investment, or last investment investors is currently available. Chondrometrics GmbH demonstrates promising potential in contributing to the advancement of medical research and pharmaceutical development.